| P50 | author | Subhash Verma | Q57951657 |
| | Erle S Robertson | Q88590600 |
| P2093 | author name string | Jie Lu | |
| | Qiliang Cai | |
| P2860 | cites work | Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells | Q24527215 |
| | Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. | Q24531182 |
| | Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus | Q24561400 |
| | Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization | Q24648127 |
| | Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 |
| | The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen | Q24672438 |
| | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes | Q24673761 |
| | Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 |
| | Early events associated with infection of Epstein-Barr virus infection of primary B-cells | Q28476230 |
| | A highly efficient recombineering-based method for generating conditional knockout mutations | Q29615157 |
| | Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 |
| | EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors | Q33261811 |
| | K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis | Q33303677 |
| | Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients | Q33432729 |
| | Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection | Q33508240 |
| | The role of HHV-8 in Kaposi's sarcoma | Q33644229 |
| | Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression | Q33653424 |
| | Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway | Q33737793 |
| | Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus). | Q33841257 |
| | Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency | Q33843211 |
| | The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters | Q33845947 |
| | DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus | Q33853499 |
| | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity | Q33922095 |
| | Notch signaling: the core pathway and its posttranslational regulation | Q34017623 |
| | Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1) | Q34069105 |
| | Convergence of Kaposi's Sarcoma-Associated Herpesvirus Reactivation with Epstein-Barr Virus Latency and Cellular Growth Mediated by the Notch Signaling Pathway in Coinfected Cells | Q34178226 |
| | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency | Q34194120 |
| | Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR | Q34340317 |
| | A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. | Q34531461 |
| | Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma | Q34571278 |
| | Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. | Q34648229 |
| | Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma | Q34735185 |
| | Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator | Q34782463 |
| | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces Expression of the Helix-Loop-Helix Protein Id-1 in Human Endothelial Cells | Q34976840 |
| | Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA | Q35080754 |
| | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta | Q35104781 |
| | Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen | Q35123088 |
| | Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest | Q35139294 |
| | Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling | Q35168476 |
| | Functional characterization of Kaposi's sarcoma-associated herpesvirus ORF45 by bacterial artificial chromosome-based mutagenesis | Q35185925 |
| | The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc | Q36099076 |
| | Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency | Q36538689 |
| | Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency | Q36540187 |
| | KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor | Q36591375 |
| | Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3beta | Q37204595 |
| | The Notch signaling pathway: transcriptional regulation at Notch target genes | Q37376057 |
| | Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma | Q37535731 |
| | Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays | Q38305362 |
| | Wide-scale use of Notch signaling factor CSL/RBP-Jkappa in RTA-mediated activation of Kaposi's sarcoma-associated herpesvirus lytic genes | Q38348963 |
| | Evaluation of the lytic origins of replication of Kaposi's sarcoma-associated virus/human herpesvirus 8 in the context of the viral genome | Q38760706 |
| | A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant | Q39539612 |
| | Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin | Q39629572 |
| | Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency | Q39665994 |
| | Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling | Q39673166 |
| | Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores | Q39675686 |
| | Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis | Q39683622 |
| | Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates latency-associated nuclear protein-mediated suppression of lytic origin-dependent DNA synthesis | Q39833695 |
| | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation | Q39852047 |
| | The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. | Q39860135 |
| | Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 |
| | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. | Q39992257 |
| | Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. | Q40002946 |
| | Gamma delta+ T cells involvement in viral immune control of chronic human herpesvirus 8 infection | Q40010164 |
| | Overexpression of the kaposi's sarcoma-associated herpesvirus transactivator K-Rta can complement a K-bZIP deletion BACmid and yields an enhanced growth phenotype | Q40072559 |
| | A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia | Q40106826 |
| | Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen | Q40169138 |
| | Ets-1-dependent expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus through interaction with Daxx | Q40252446 |
| | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function | Q40335991 |
| | Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. | Q40364647 |
| | New viruses shake old paradigms | Q40364721 |
| | Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. | Q40486158 |
| | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest | Q40496132 |
| | RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA | Q40546002 |
| | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter | Q40811288 |
| | In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences | Q40971183 |
| | Human herpesvirus-8: detection of novel herpesvirus-like DNA sequences in Kaposi's sarcoma and other lesions | Q41126577 |
| | Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells | Q41191622 |
| | Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture | Q41225141 |
| | KSHV and Kaposi's sarcoma: the end of the beginning? | Q41622722 |
| | Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen | Q41849965 |
| | Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions | Q42049779 |
| | A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication | Q42150768 |
| | Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells | Q42710003 |
| | Cytomegalovirus and human herpesvirus 8 DNA detection in peripheral blood monocytic cells of AIDS patients: correlations with the presence of Kaposi's sarcoma and CMV disease | Q45246332 |
| | Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how? | Q45749153 |
| | Propagating Kaposi's sarcoma-associated herpesvirus | Q71957790 |
| | Latent and lytic HHV-8 mRNA expression in PBMCs and Kaposi's sarcoma skin biopsies of AIDS Kaposi's sarcoma patients | Q73497577 |
| | Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy | Q74344820 |
| | Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein | Q77760836 |
| | Relationship between human herpesvirus 8 loads and disease stage in classic Kaposi sarcoma patients | Q80086361 |
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6148-6161 | |
| P577 | publication date | 2011-04-20 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection | |
| P478 | volume | 85 | |